BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36513718)

  • 1. Pan-cancer functional analysis of somatic mutations in G protein-coupled receptors.
    Bongers BJ; Gorostiola González M; Wang X; van Vlijmen HWT; Jespers W; Gutiérrez-de-Terán H; Ye K; IJzerman AP; Heitman LH; van Westen GJP
    Sci Rep; 2022 Dec; 12(1):21534. PubMed ID: 36513718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent high-impact mutations at cognate structural positions in class A G protein-coupled receptors expressed in tumors.
    Huh E; Gallion J; Agosto MA; Wright SJ; Wensel TG; Lichtarge O
    Proc Natl Acad Sci U S A; 2021 Dec; 118(51):. PubMed ID: 34916293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPCRs show widespread differential mRNA expression and frequent mutation and copy number variation in solid tumors.
    Sriram K; Moyung K; Corriden R; Carter H; Insel PA
    PLoS Biol; 2019 Nov; 17(11):e3000434. PubMed ID: 31765370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Getting from A to B-exploring the activation motifs of the class B adhesion G protein-coupled receptor subfamily G member 4/GPR112.
    Peeters MC; Mos I; Lenselink EB; Lucchesi M; IJzerman AP; Schwartz TW
    FASEB J; 2016 May; 30(5):1836-48. PubMed ID: 26823453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-omics integration analysis of GPCRs in pan-cancer to uncover inter-omics relationships and potential driver genes.
    Li S; Chen X; Chen J; Wu B; Liu J; Guo Y; Li M; Pu X
    Comput Biol Med; 2023 Jul; 161():106988. PubMed ID: 37201441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The highly conserved DRY motif of class A G protein-coupled receptors: beyond the ground state.
    Rovati GE; Capra V; Neubig RR
    Mol Pharmacol; 2007 Apr; 71(4):959-64. PubMed ID: 17192495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy.
    Wu V; Yeerna H; Nohata N; Chiou J; Harismendy O; Raimondi F; Inoue A; Russell RB; Tamayo P; Gutkind JS
    J Biol Chem; 2019 Jul; 294(29):11062-11086. PubMed ID: 31171722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G Protein-Coupled Receptors in Cancer.
    Bar-Shavit R; Maoz M; Kancharla A; Nag JK; Agranovich D; Grisaru-Granovsky S; Uziely B
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27529230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Established and In-trial GPCR Families in Clinical Trials: A Review for Target Selection.
    Saikia S; Bordoloi M; Sarmah R
    Curr Drug Targets; 2019; 20(5):522-539. PubMed ID: 30394207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ancient Link between G-Protein-Coupled Receptors and C-Terminal Phospholipid Kinase Domains.
    van den Hoogen DJ; Meijer HJG; Seidl MF; Govers F
    mBio; 2018 Jan; 9(1):. PubMed ID: 29362235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-coupled receptors as promising cancer targets.
    Liu Y; An S; Ward R; Yang Y; Guo XX; Li W; Xu TR
    Cancer Lett; 2016 Jul; 376(2):226-39. PubMed ID: 27000991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The G protein G
    Bondar A; Lazar J
    J Biol Chem; 2017 Jun; 292(23):9690-9698. PubMed ID: 28438833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer.
    O'Hayre M; Vázquez-Prado J; Kufareva I; Stawiski EW; Handel TM; Seshagiri S; Gutkind JS
    Nat Rev Cancer; 2013 Jun; 13(6):412-24. PubMed ID: 23640210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7TM Domain Structure of Adhesion GPCRs.
    de Graaf C; Nijmeijer S; Wolf S; Ernst OP
    Handb Exp Pharmacol; 2016; 234():43-66. PubMed ID: 27832483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomic and structural analysis of constitutive g protein-coupled receptor activity.
    Smit MJ; Vischer HF; Bakker RA; Jongejan A; Timmerman H; Pardo L; Leurs R
    Annu Rev Pharmacol Toxicol; 2007; 47():53-87. PubMed ID: 17029567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Based Sequence Alignment of the Transmembrane Domains of All Human GPCRs: Phylogenetic, Structural and Functional Implications.
    Cvicek V; Goddard WA; Abrol R
    PLoS Comput Biol; 2016 Mar; 12(3):e1004805. PubMed ID: 27028541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPCR-2L: predicting G protein-coupled receptors and their types by hybridizing two different modes of pseudo amino acid compositions.
    Xiao X; Wang P; Chou KC
    Mol Biosyst; 2011 Mar; 7(3):911-9. PubMed ID: 21180772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic mass redistribution reveals diverging importance of PDZ-ligands for G protein-coupled receptor pharmacodynamics.
    Camp ND; Lee KS; Cherry A; Wacker-Mhyre JL; Kountz TS; Park JM; Harris DA; Estrada M; Stewart A; Stella N; Wolf-Yadlin A; Hague C
    Pharmacol Res; 2016 Mar; 105():13-21. PubMed ID: 26773201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a sequence motif characteristic of aminergic G protein-coupled receptors.
    Huang ES
    Protein Sci; 2003 Jul; 12(7):1360-7. PubMed ID: 12824482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Motions around conserved helical weak spots facilitate GPCR activation.
    Bibbe JM; Vriend G
    Proteins; 2021 Nov; 89(11):1577-1586. PubMed ID: 34272892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.